Purpose: Renal cancer response to interleukin 2 (IL-2) therapy and patient survival has
been correlated with tumor histology and carbonic anhydrase IX (CAIX) expression. In an …

OBJECTIVES: To validate enzyme-linked immunosorbent assay (ELISA) as an accurate and
objective method to measure carbonic anhydrase IX (CAIX) expression in RCC tissue …

Purpose Expression of carbonic anhydrase IX (CAIX) has been reported to be an
independent predictor of outcome and is being investigated as a therapeutic target for …

Purpose: Metastatic renal cell carcinoma (RCC) has a poor prognosis and an unpredictable
course. To date, there are no molecular markers which can reliably predict RCC outcome …

CONTEXT: The clinical management of patients with renal cell carcinoma (RCC) remains
difficult, and the development of new diagnostic, prognostic, and therapeutic tools is still …

Carbonic anhydrase IX (CAIX)—a protein maintaining intracellular and extracellular pH—
reportedly also influences regulation of cell proliferation, oncogenesis, and tumor …

Carbonic anhydrase IX (CAIX), a hypoxia-induced protein, is expressed in some renal
tumors. We evaluated its immunohistochemical expression in 317 primary and 42 metastatic …

OBJECTIVE To evaluate the prognostic information of carbonic anhydrase (CA) IX
expression in patients with renal cell carcinoma (RCC), as increased expression of CA IX is …

Carbonic Anhydrase IX (CAIX) is a well-described enzyme in renal cell carcinoma, with its
expression being regulated by the hypoxia-inducible factor 1 alpha, it is known for interfering …

BACKGROUND: The objective of this study was to evaluate the role of carbonic anhydrase
IX (CAIX) in urothelial carcinoma of the bladder. METHODS: A tissue microarray was …